journal article·2024-06-19

Personalized Nanovaccines Enhance Lymph Node Accumulation and Reprogram the Tumor Microenvironment for Improved Photodynamic Immunotherapy

Ruoning Wang, Jinge Li, Xiaohong Wang, Yingjie Zhang, Anran Zhu, Kuanhan Feng, Junsong Li, Liuqing Di

Nano Letters· Volume 24· Issue 24
Publisher page

Abstract

Tumor immunotherapy has emerged as an efficacious therapeutic approach that mobilizes the patient’s immune system to achieve durable tumor suppression. Here, we design a photodynamic therapy-motivated nanovaccine (Dex-HDL/ALA-Fe 3 O 4 ) co-delivering 5-aminolevulinic acid and Fe 3 O 4 nanozyme that demonstrate a long-term durable immunotherapy strategy. After vaccination, the nanovaccine exhibits obvious tumor site accumulation, lymph node homing, and specific and memory antitumor immunity evocation. Upon laser irradiation, Dex-HDL/ALA-Fe 3 O 4 effectively generates reactive oxygen species at the tumor site not only to induce the immunogenic cell death-cascade but also to trigger the on-demand release of full types of tumor antigens. Intriguingly, Fe 3 O 4 nanozyme-catalyzed hydrogen peroxide generated oxygen for alleviating tumor hypoxia and modifying the inhibitory tumor microenvironment, thereby exhibiting remarkable potential as a sensitizer. The intravenous administration of nanovaccines in diverse preclinical cancer models has demonstrated remarkable tumor regression and inhibition of postoperative tumor recurrence and metastasis, thereby enabling personalized treatment strategies against highly heterogeneous tumors.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China

Jiangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing 210023, China

Funding

Nanjing University of Chinese Medicine · China Academy of Chinese Medical Sciences · National Natural Science Foundation of China

References (37)

Show source-provided references
1. 10.1016/j.cell.2022.06.03510.1016/j.cell.2022.06.035 ↗
2. 10.1038/s43018-022-00382-110.1038/s43018-022-00382-1 ↗
3. 10.1016/j.immuni.2019.12.01110.1016/j.immuni.2019.12.011 ↗
4. 10.1126/scitranslmed.abo360510.1126/scitranslmed.abo3605 ↗
5. 10.1038/nrd322010.1038/nrd3220 ↗
6. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗
7. 10.1002/adma.20210379010.1002/adma.202103790 ↗
8. 10.1002/adma.20220105410.1002/adma.202201054 ↗
9. 10.1016/j.addr.2021.04.02710.1016/j.addr.2021.04.027 ↗
10. 10.1186/s12943-022-01515-x10.1186/s12943-022-01515-x ↗
11. 10.1038/s41467-023-39759-w10.1038/s41467-023-39759-w ↗
12. 10.1126/scitranslmed.aao593110.1126/scitranslmed.aao5931 ↗
13. 10.1080/20013078.2020.179536210.1080/20013078.2020.1795362 ↗
14. 10.1186/s13045-020-00939-610.1186/s13045-020-00939-6 ↗
15. 10.1021/acs.nanolett.2c0378410.1021/acs.nanolett.2c03784 ↗
16. 10.1038/s41598-023-38862-810.1038/s41598-023-38862-8 ↗
17. 10.1021/acs.nanolett.4c0047110.1021/acs.nanolett.4c00471 ↗
18. 10.1021/acs.nanolett.3c0381610.1021/acs.nanolett.3c03816 ↗
19. 10.1073/pnas.220462112010.1073/pnas.2204621120 ↗
20. 10.1016/j.mattod.2022.01.02410.1016/j.mattod.2022.01.024 ↗
21. 10.1021/acsami.3c0737910.1021/acsami.3c07379 ↗
22. 10.1002/advs.20230133910.1002/advs.202301339 ↗
23. 10.1021/acsnano.3c0646210.1021/acsnano.3c06462 ↗
24. 10.1038/nri.2017.13110.1038/nri.2017.131 ↗
25. 10.1038/s41467-019-13896-710.1038/s41467-019-13896-7 ↗
26. 10.1126/sciadv.adk244410.1126/sciadv.adk2444 ↗
27. 10.1002/advs.20210607210.1002/advs.202106072 ↗
28. 10.1002/adma.20200724710.1002/adma.202007247 ↗
29. 10.1002/adma.20210109510.1002/adma.202101095 ↗
30. 10.1016/j.jconrel.2023.01.02310.1016/j.jconrel.2023.01.023 ↗
31. 10.1002/adma.20230719310.1002/adma.202307193 ↗
32. 10.1002/anie.20231260310.1002/anie.202312603 ↗
33. 10.1021/acsnano.2c1021910.1021/acsnano.2c10219 ↗
34. 10.1016/j.immuni.2023.07.01010.1016/j.immuni.2023.07.010 ↗
35. 10.1002/adfm.20221140210.1002/adfm.202211402 ↗
36. 10.1002/adma.20220759310.1002/adma.202207593 ↗
37. 10.1073/pnas.221038512010.1073/pnas.2210385120 ↗